BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
MENLO PARK, Calif., March 08, 2016 -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, March 30, 2016 at 8 a.m. Pacific time to discuss its results for the third quarter fiscal 2016. Financial results will be reported for the 2016 fiscal third quarter ended February 28, 2016 after market close on March 29, 2016.
Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Wednesday, March 30, 2016
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (866) 814-1914
U.S. and International Toll Number: (703) 639-1358
Conference ID: 1670124
Webcast: www.Landec.com/earningscall
The webcast will be available for 30 days through April 29, 2016.
A replay of the teleconference will be available for one week until midnight Eastern Time, Wednesday, April 6, 2016.
Toll free replay dial in: 888-266-2081
International replay: 703-925-2533
Replay passcode: 1670124
About Landec Corporation
Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP (current good manufacturing practices) validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the company, visit Landec's website at www.landec.com.
CONTACT: Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: Liolios Group, Inc. Matt Glover (949)574-3860 [email protected]
